Krishna Institute of Medical Sciences Limited
NSE:KIMS.NS
632 (INR) • At close May 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 24,981.44 | 21,976.78 | 16,508.25 | 13,299.37 | 11,226.45 | 9,180.05 | 6,636.71 | 5,671.38 | 5,118.17 | 4,222.08 | 3,569.08 | 2,943.12 |
| Kosten van de omzet
| 10,158.07 | 8,793.14 | 6,170.63 | 9,108.08 | 4,522.14 | 3,732.35 | 4,982.99 | 4,587.7 | 4,101.83 | 3,565.53 | 3,375.43 | 2,633.62 |
| Brutowinst
| 14,823.37 | 13,183.64 | 10,337.62 | 4,191.29 | 6,704.31 | 5,447.7 | 1,653.72 | 1,083.68 | 1,016.34 | 656.55 | 193.65 | 309.5 |
| Brutowinstmarge
| 0.593 | 0.6 | 0.626 | 0.315 | 0.597 | 0.593 | 0.249 | 0.191 | 0.199 | 0.156 | 0.054 | 0.105 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 243.16 | 4,646.48 | 3,102.42 | 2,717.88 | 2,563.78 | 2,164.15 | 52.02 | 1,666.13 | 1,509.42 | 1,283.93 | 0 | 0 |
| Verkoop- en marketingkosten
| 251.59 | 197.39 | 111.51 | 91.81 | 113.01 | 106.62 | 65.94 | 57.29 | 65.94 | 22.99 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 494.75 | 4,843.87 | 3,213.93 | 2,809.69 | 2,676.79 | 2,270.77 | 566.27 | 202.07 | 206.85 | 126.56 | 34.63 | 32.82 |
| Overige kosten
| 0 | 3,667.2 | 2,692.53 | 2,292.91 | 4,027.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 494.75 | 8,511.07 | 5,906.46 | 5,080.83 | 4,846.18 | 5,447.7 | 639.01 | 243.44 | 248.51 | 161.35 | 20.78 | 25.31 |
| Bedrijfsresultaat
| 14,328.62 | 4,894.74 | 4,471.43 | 3,088.37 | 1,811.51 | 1,223.9 | 1,014.71 | 840.24 | 767.83 | 478.77 | 159.02 | 276.68 |
| Bedrijfsresultaat ratio
| 0.574 | 0.223 | 0.271 | 0.232 | 0.161 | 0.133 | 0.153 | 0.148 | 0.15 | 0.113 | 0.045 | 0.094 |
| Totaal overige inkomsten en kosten netto
| -9,732.25 | -45.67 | 97.1 | -298.22 | -406.25 | -1,377.71 | -1,228.15 | -312.4 | -358.81 | -345.85 | 13.85 | 0.76 |
| Inkomen voor belasting
| 4,596.37 | 4,849.07 | 4,568.53 | 2,790.15 | 1,405.26 | -153.81 | -213.44 | 527.84 | 409.02 | 132.92 | 172.87 | 277.44 |
| Inkomen voor belasting ratio
| 0.184 | 0.221 | 0.277 | 0.21 | 0.125 | -0.017 | -0.032 | 0.093 | 0.08 | 0.031 | 0.048 | 0.094 |
| Belastingkosten
| 1,236.3 | 1,190.94 | 1,130.58 | 735.36 | 254.54 | 334.26 | 257.4 | 192.99 | 129.28 | 69.29 | 103.29 | 95.37 |
| Nettowinst
| 3,101.47 | 3,363.22 | 3,326.85 | 2,012.19 | 1,191.83 | -477.69 | -473.55 | 325.56 | 266.15 | 56.08 | 69.47 | 188.82 |
| Nettowinstmarge
| 0.124 | 0.153 | 0.202 | 0.151 | 0.106 | -0.052 | -0.071 | 0.057 | 0.052 | 0.013 | 0.019 | 0.064 |
| WPA (Winst Per Aandeel)
| 7.75 | 8.41 | 8.38 | 5.37 | 3.2 | -1.19 | -1.89 | 0.92 | 0.76 | 0.16 | 0.2 | 0.54 |
| Verwaterde WPA
| 7.75 | 8.41 | 8.38 | 5.28 | 3.17 | -1.19 | -1.89 | 0.92 | 0.76 | 0.16 | 0.2 | 0.54 |
| EBITDA
| 6,526.19 | 6,514.46 | 5,418.9 | 3,778.66 | 2,498.88 | 857.79 | 1,068.69 | 1,204.18 | 1,134.41 | 800.45 | 405.92 | 637.81 |
| EBITDA ratio
| 0.261 | 0.296 | 0.328 | 0.284 | 0.223 | 0.093 | 0.161 | 0.212 | 0.222 | 0.19 | 0.114 | 0.217 |